Stock listing
NASDAQ:AGMB AgomAb Therapeutics NV Stock
Follow AgomAb Therapeutics NV into a list and get an email when it puts out news.
Share price · NASDAQ:AGMB
$7.49 USD -0.46 (-5.8%)
Close on Oct 30, 2026
- Day range
- $6.61 – $7.96 USDOct 30, 2026
- Volume
- 197,833 sharesOct 30, 2026
- Market cap
- $368.9M USDAt the close on Oct 30, 2026 · price × 49.25M shares outstanding
- Traded on an average day
- $1.70M USDMedian day 105,150 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:AGMB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.49 | -0.46 | -5.8% | $7.00 | $7.955 | $6.61 | 197,833 | |
| $7.95 | -0.01 | -0.1% | $7.98 | $8.292 | $7.47 | 575,393 | |
| $7.96 | -0.44 | -5.2% | $8.37 | $8.37 | $7.71 | 105,583 | |
| $8.40 | -0.17 | -2.0% | $8.60 | $8.60 | $7.88 | 89,797 | |
| $8.57 | -0.48 | -5.3% | $9.10 | $9.33 | $8.44 | 73,647 | |
| $9.05 | -0.21 | -2.3% | $9.15 | $9.184 | $8.675 | 49,125 | |
| $9.26 | +0.15 | +1.6% | $9.15 | $9.44 | $8.90 | 84,322 | |
| $9.11 | +0.38 | +4.4% | $8.74 | $9.22 | $8.74 | 42,422 | |
| $8.73 | +0.50 | +6.1% | $8.24 | $8.97 | $8.23 | 35,303 | |
| $8.23 | -0.05 | -0.6% | $8.28 | $8.61 | $8.16 | 31,092 | |
| $8.28 | -0.05 | -0.6% | $8.21 | $8.53 | $7.92 | 78,133 | |
| $8.33 | -0.36 | -4.1% | $8.56 | $8.86 | $8.15 | 97,715 | |
| $8.69 | -0.12 | -1.4% | $8.80 | $9.08 | $8.51 | 57,697 | |
| $8.81 | -0.28 | -3.1% | $9.05 | $9.35 | $8.73 | 59,400 | |
| $9.09 | +0.01 | +0.1% | $9.18 | $9.65 | $9.05 | 62,300 | |
| $9.08 | -0.14 | -1.5% | $9.36 | $9.49 | $8.92 | 102,100 | |
| $9.22 | +0.42 | +4.8% | $8.88 | $9.45 | $8.56 | 225,200 | |
| $8.80 | -0.04 | -0.5% | $8.95 | $9.35 | $8.68 | 104,900 | |
| $8.84 | +0.15 | +1.7% | $8.77 | $8.97 | $8.40 | 103,900 | |
| $8.69 | +0.13 | +1.5% | $8.51 | $8.71 | $7.97 | 129,600 | |
| $8.56 | -0.09 | -1.0% | $8.65 | $9.34 | $8.00 | 388,700 | |
| $8.65 | -2.45 | -22.1% | $11.21 | $11.32 | $8.56 | 639,200 | |
| $11.10 | +0.57 | +5.4% | $10.62 | $11.36 | $10.58 | 133,700 | |
| $10.53 | +0.32 | +3.1% | $10.23 | $10.69 | $10.14 | 113,500 | |
| $10.21 | -0.30 | -2.9% | $10.51 | $10.54 | $9.87 | 147,200 | |
| $10.51 | -0.07 | -0.7% | $10.65 | $11.23 | $10.41 | 164,000 | |
| $10.58 | -0.19 | -1.8% | $10.75 | $10.99 | $10.50 | 64,200 | |
| $10.77 | -0.72 | -6.3% | $11.54 | $11.80 | $10.64 | 98,700 | |
| $11.49 | -0.21 | -1.8% | $11.70 | $11.85 | $11.31 | 49,400 | |
| $11.70 | -0.47 | -3.9% | $12.26 | $12.26 | $11.28 | 85,400 | |
| $12.17 | +0.09 | +0.7% | $12.26 | $12.99 | $11.60 | 250,700 | |
| $12.08 | +0.67 | +5.9% | $11.66 | $12.46 | $11.62 | 339,300 | |
| $11.41 | -0.75 | -6.2% | $12.26 | $12.85 | $11.21 | 120,300 | |
| $12.16 | -0.12 | -1.0% | $12.31 | $12.92 | $11.61 | 146,300 | |
| $12.28 | -0.78 | -6.0% | $13.20 | $13.29 | $12.20 | 86,200 | |
| $13.06 | -0.88 | -6.3% | $14.00 | $14.10 | $12.96 | 196,700 | |
| $13.94 | -1.02 | -6.8% | $14.91 | $16.40 | $13.75 | 106,700 | |
| $14.96 | +0.05 | +0.3% | $14.94 | $15.70 | $14.65 | 72,600 | |
| $14.91 | -0.87 | -5.5% | $15.78 | $16.50 | $14.51 | 260,600 | |
| $15.78 | +0.95 | +6.4% | $14.83 | $15.86 | $14.53 | 245,300 | |
| $14.83 | +1.17 | +8.6% | $13.67 | $14.94 | $13.59 | 407,900 | |
| $13.66 | +0.12 | +0.9% | $13.29 | $13.96 | $13.19 | 158,900 | |
| $13.54 | +0.37 | +2.8% | $12.90 | $13.99 | $12.62 | 241,300 | |
| $13.17 | 0.00 | 0.0% | $13.15 | $14.13 | $12.75 | 105,400 | |
| $13.17 | -0.67 | -4.8% | $13.84 | $14.20 | $12.84 | 252,900 | |
| $13.84 | -0.44 | -3.1% | $14.26 | $14.37 | $13.66 | 154,200 | |
| $14.28 | +0.26 | +1.9% | $14.19 | $14.60 | $13.58 | 243,700 | |
| $14.02 | +1.20 | +9.4% | $13.40 | $14.26 | $13.16 | 219,354 | |
| $12.82 | -0.43 | -3.2% | $13.21 | $13.23 | $12.76 | 31,651 | |
| $13.25 | -0.18 | -1.3% | $13.50 | $13.64 | $13.07 | 68,400 | |
| $13.43 | -0.32 | -2.3% | $13.74 | $13.85 | $13.01 | 92,200 | |
| $13.75 | +0.02 | +0.1% | $13.81 | $14.42 | $13.59 | 137,400 | |
| $13.73 | +0.05 | +0.4% | $13.62 | $13.86 | $13.42 | 30,900 | |
| $13.68 | +0.46 | +3.5% | $13.25 | $13.90 | $13.02 | 119,300 | |
| $13.22 | -0.73 | -5.2% | $14.03 | $14.03 | $13.03 | 42,000 | |
| $13.95 | -0.16 | -1.1% | $14.24 | $14.29 | $13.75 | 241,600 | |
| $14.11 | -0.74 | -5.0% | $14.85 | $15.58 | $13.80 | 151,400 | |
| $14.85 | -0.15 | -1.0% | $15.10 | $15.50 | $14.53 | 60,988 | |
| $15.00 | +0.50 | +3.4% | $14.53 | $15.44 | $13.64 | 87,437 | |
| $14.50 | +1.00 | +7.4% | $13.62 | $14.50 | $13.15 | 367,400 | |
| $13.50 | -0.82 | -5.7% | $14.44 | $14.50 | $13.31 | 38,600 | |
| $14.32 | -0.41 | -2.8% | $14.91 | $14.91 | $14.16 | 29,100 | |
| $14.73 | +1.21 | +8.9% | $13.75 | $14.87 | $13.67 | 87,400 | |
| $13.52 | +0.65 | +5.1% | $12.63 | $13.52 | $12.41 | 126,000 | |
| $12.87 | +0.11 | +0.9% | $12.76 | $13.00 | $12.26 | 54,100 | |
| $12.76 | +0.36 | +2.9% | $12.66 | $13.16 | $12.19 | 68,900 |
- Ticker
- NASDAQ:AGMB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 13, 2026
Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease
Latest deck · Oct 1, 2026
Investor Presentation (October 2026)
Investor deck · 29 slides
Latest news
Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease
Oct 13, 2026
Closed $8.69 (-1.4%) on Oct 14, 2026
Agomab to Present STENOVA Open-Label Extension Data of Ontunisertib at UEG Week 2026 and Host Scientific Symposium on Fibro-Inflammation
Oct 8, 2026
Closed $9.08 (-1.5%) on Oct 9, 2026
Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease
Oct 1, 2026
Closed $8.65 (-22.1%) on Oct 1, 2026
Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
Sep 14, 2026
Closed $12.16 (-1.0%) on Sep 15, 2026
Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
Sep 11, 2026
Closed $12.28 (-6.0%) on Sep 14, 2026
Agomab to Participate in Upcoming Investor Conferences
Sep 3, 2026
Closed $15.78 (+6.4%) on Sep 4, 2026
Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook
Aug 6, 2026
Closed $14.50 (+7.4%) on Aug 7, 2026
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
Jun 23, 2026
Closed $12.68 (+6.2%) on Jun 24, 2026
Agomab Announces Results of Annual General Meeting
May 27, 2026
Closed $11.67 (+5.6%) on May 27, 2026
Agomab to Participate in Upcoming Conferences
May 14, 2026
Closed $11.04 (-1.3%) on May 14, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 29 slides · Oct 1, 2026
Investor Presentation (August 2026)
Investor deck · 50 slides · August 2026
AgomAb Therapeutics NV on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 15 in all · newest Oct 13, 2026 · oldest 2026
- Decks
- 2 decks · latest Oct 1, 2026
Log in to ask 6ix AI your own questions about AgomAb Therapeutics NV.